|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Five Prime Therapeutics Inc (FPRX) |
|
|
$38.00 0.00 (0.00%) as of 4:30 Thu 4/15
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
46,320,000 |
| Market
Cap: |
1.76(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$38 - $38 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-04 |
2023-11-03 |
2023-05-05 |
2022-05-05 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Knickerbocker Aron Marc |
President & CEO |
• • – |
2018-08-22 |
4 |
OE |
$11.14 |
$5,570 |
D/D |
500 |
194,867 |
|
- |
|
| Knickerbocker Aron Marc |
President & CEO |
• • – |
2018-08-21 |
4 |
OE |
$11.14 |
$5,570 |
D/D |
500 |
194,367 |
|
- |
|
| Knickerbocker Aron Marc |
President & CEO |
• • – |
2018-08-20 |
4 |
OE |
$11.14 |
$5,570 |
D/D |
500 |
193,867 |
|
- |
|
| Knickerbocker Aron Marc |
President & CEO |
• • – |
2018-08-15 |
4 |
OE |
$11.14 |
$5,570 |
D/D |
500 |
193,367 |
|
- |
|
| Knickerbocker Aron Marc |
President & CEO |
• • – |
2018-08-13 |
4 |
OE |
$11.14 |
$5,570 |
D/D |
500 |
192,867 |
|
- |
|
| Knickerbocker Aron Marc |
President & CEO |
• • – |
2018-08-08 |
4 |
OE |
$11.14 |
$5,570 |
D/D |
500 |
192,367 |
|
- |
|
| Knickerbocker Aron Marc |
President & CEO |
• • – |
2018-08-07 |
4 |
OE |
$11.14 |
$5,570 |
D/D |
500 |
191,867 |
|
- |
|
| Collins Helen Louise |
SVP and Chief Medical Officer |
• – – |
2018-06-23 |
4 |
D |
$17.38 |
$21,551 |
D/D |
(1,240) |
32,725 |
|
- |
|
| Knickerbocker Aron Marc |
President & CEO |
• • – |
2018-06-08 |
4 |
GD |
$0.00 |
$0 |
I/I |
845 |
14,238 |
|
- |
|
| Irving Bryan |
EVP, Chief Scientific Officer |
• – – |
2018-05-15 |
4/A |
A |
$0.00 |
$0 |
D/D |
3,750 |
24,750 |
|
- |
|
| Irving Bryan |
EVP, Chief Scientific Officer |
• – – |
2018-05-10 |
4 |
A |
$0.00 |
$0 |
D/D |
3,750 |
24,750 |
|
- |
|
| Collins Helen Louise |
SVP and Chief Medical Officer |
• – – |
2018-03-20 |
4 |
D |
$16.26 |
$13,447 |
D/D |
(827) |
33,965 |
|
- |
|
| Belsky Marc |
Senior Vice President and CFO |
• – – |
2018-02-05 |
4 |
D |
$18.42 |
$19,304 |
D/D |
(1,048) |
13,314 |
|
- |
|
| Williams Lewis T |
Executive Chairman |
• • – |
2018-02-05 |
4 |
D |
$18.42 |
$57,784 |
D/D |
(3,137) |
376,237 |
|
- |
|
| Baker Kevin Paul |
SVP, Development Sciences |
• – – |
2018-02-05 |
4 |
D |
$18.42 |
$17,131 |
D/D |
(930) |
74,684 |
|
- |
|
| Collins Helen Louise |
SVP and Chief Medical Officer |
• – – |
2018-02-05 |
4 |
D |
$18.42 |
$19,304 |
D/D |
(1,048) |
23,732 |
|
- |
|
| Baker Kevin Paul |
SVP, Development Sciences |
• – – |
2018-02-01 |
4 |
D |
$19.73 |
$372,226 |
D/D |
(18,866) |
75,614 |
|
- |
|
| Knickerbocker Aron Marc |
Chief Operating Officer |
• • – |
2017-11-29 |
4 |
OE |
$5.54 |
$34,210 |
D/D |
6,175 |
177,521 |
|
- |
|
| Ringo William R |
Director |
– • – |
2017-11-01 |
4 |
AS |
$45.33 |
$27,198 |
D/D |
(600) |
0 |
|
- |
|
| Ringo William R |
Director |
– • – |
2017-11-01 |
4 |
OE |
$11.65 |
$6,990 |
D/D |
600 |
600 |
|
- |
|
| Knickerbocker Aron Marc |
Chief Operating Officer |
• • – |
2017-10-12 |
4 |
OE |
$7.26 |
$81,947 |
D/D |
11,051 |
171,346 |
|
- |
|
| Ringo William R |
Director |
– • – |
2017-10-02 |
4 |
AS |
$40.78 |
$24,468 |
D/D |
(600) |
0 |
|
- |
|
| Ringo William R |
Director |
– • – |
2017-10-02 |
4 |
OE |
$11.65 |
$6,990 |
D/D |
600 |
600 |
|
- |
|
| Ringo William R |
Director |
– • – |
2017-09-29 |
4 |
AS |
$40.00 |
$48,000 |
D/D |
(1,200) |
0 |
|
- |
|
| Ringo William R |
Director |
– • – |
2017-09-29 |
4 |
OE |
$11.65 |
$13,980 |
D/D |
1,200 |
1,200 |
|
- |
|
319 Records found
|
|
Page 6 of 13 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
